• 1. Aromatic nucleophilic substitution of hydrogen: reactions of 6-nitroquinoline with potassium cyanide and nitroalkanes
  Ale? Halama,Vladimír Machá?ek J. Chem. Soc. Perkin Trans. 1 1999 2495
• 2. Aromatic nucleophilic substitution of hydrogen: mechanism of reaction of 6-nitroquinoline with cyanide ions, with and without participation of methyl cyanoacetate
  Ale? Halama,Jaromír Kaválek,Vladimír Machá?ek,Tomá? Weidlich J. Chem. Soc. Perkin Trans. 1 1999 1839
• 3. Direct thioalkylation of nitroquinolines with alkanethiolate anions via nucleophilic displacement of a ring hydrogen atom
  Takehiko Kawakami,Hitomi Suzuki J. Chem. Soc. Perkin Trans. 1 2000 3640
• 4. A straightforward synthesis of some fused aza-arenes via nucleophilic displacement of a ring hydrogen atom in nitroarenes by aromatic hydrazone anions
  Koji Uehata,Takehiko Kawakami,Hitomi Suzuki via nucleophilic displacement of a ring hydrogen atom in nitroarenes by aromatic hydrazone anions. Koji Uehata Takehiko Kawakami Hitomi Suzuki J. Chem. Soc. Perkin Trans. 1 2002 696
• 5. 349. Derivatives of 4-chloro- and 6-nitro-quinoline
  J. C. E. Simpson,P. H. Wright J. Chem. Soc. 1948 1707

Introduction to 6-Nitroquinoline (CAS No. 613-50-3)

6-Nitroquinoline, identified by the chemical compound code CAS No. 613-50-3, is a nitro-substituted derivative of quinoline. This heterocyclic aromatic compound has garnered significant attention in the field of pharmaceutical chemistry and medicinal research due to its unique structural and functional properties. Quinoline and its derivatives have a long-standing history in medicinal chemistry, with applications ranging from antimalarial agents to anticancer drugs. The introduction of a nitro group at the 6-position of the quinoline ring introduces distinct reactivity and biological activity, making it a valuable scaffold for further chemical modifications and drug development.

The chemical structure of 6-Nitroquinoline consists of a benzene-like quinoline core, which is characterized by a fused pyridine ring system. The presence of the nitro group (–NO?) at the 6-position enhances the electron-withdrawing nature of the molecule, influencing its electronic properties and potential interactions with biological targets. This modification has been strategically employed to modulate the pharmacokinetic and pharmacodynamic profiles of quinoline derivatives, thereby expanding their therapeutic potential.

Recent advancements in computational chemistry and molecular modeling have provided deeper insights into the interactions between 6-Nitroquinoline and biological macromolecules. Studies have demonstrated that the nitro group can serve as a key pharmacophore, facilitating binding to specific enzymes and receptors involved in various disease pathways. For instance, research has highlighted the potential of 6-Nitroquinoline as a lead compound in developing inhibitors for enzymes such as topoisomerases and kinases, which are critical targets in oncology.

In addition to its pharmaceutical applications, 6-Nitroquinoline has shown promise in materials science, particularly in the synthesis of functional dyes and organic semiconductors. The nitro-substituted quinoline derivatives exhibit strong absorption characteristics in the visible spectrum, making them suitable for use in optoelectronic devices such as organic light-emitting diodes (OLEDs) and photovoltaic cells. The tunable electronic properties of these compounds allow for fine adjustments in device performance, enhancing efficiency and stability.

The synthesis of 6-Nitroquinoline typically involves nitration of quinoline under controlled conditions to ensure regioselectivity at the 6-position. Advances in green chemistry have led to the development of more sustainable synthetic routes, minimizing waste generation and reducing environmental impact. These methods often employ catalytic systems that enhance reaction efficiency while maintaining high selectivity, aligning with global efforts toward sustainable pharmaceutical manufacturing.

Biological studies on 6-Nitroquinoline have revealed intriguing mechanisms of action that warrant further exploration. Preclinical trials have indicated that this compound exhibits inhibitory effects on certain cancer cell lines by interfering with DNA replication and transcription processes. The nitro group plays a pivotal role in these interactions, modulating redox-sensitive pathways within cancer cells. Such findings underscore the importance of 6-Nitroquinoline as a potential candidate for novel anticancer therapies.

Moreover, research has explored the antimicrobial properties of 6-Nitroquinoline, demonstrating its efficacy against Gram-positive bacteria and fungi. The structural features of this compound enable it to disrupt microbial cell membranes and inhibit essential metabolic pathways. These findings are particularly relevant in light of rising antibiotic resistance challenges, where novel antimicrobial agents are urgently needed.

The versatility of 6-Nitroquinoline as a chemical scaffold has also been leveraged in designing prodrugs that enhance bioavailability and target specificity. By incorporating additional functional groups or linkers into the molecule, researchers can modulate solubility, permeability, and metabolic stability. Such prodrug formulations hold promise for improving therapeutic outcomes while minimizing side effects.

In conclusion, 6-Nitroquinoline (CAS No. 613-50-3) represents a fascinating compound with broad applications across pharmaceuticals, materials science, and biotechnology. Its unique structural features, coupled with recent advancements in synthetic methodologies and biological research, position it as a cornerstone for innovation in drug discovery and material design. As scientific understanding continues to evolve, the potential applications of this remarkable molecule are expected to expand further, contributing to advancements in human health and technological progress.

• 157996-62-8(9-Acridinamine,2,7-dinitro-)
• 138835-35-5(Naphth[2,1,8-mna]acridine,1-nitro-)
• 3741-15-9(4-Nitroquinoline)
• 61653-19-8(7-Quinolinamine, compd. with 1,3,5-trinitrobenzene (1:1))
• 138835-36-6(Naphth[2,1,8-mna]acridine,3-nitro-)
• 607-34-1(5-Nitroquinoline)
• 29808-81-9(2-Nitroacridine)
• 14251-96-8(Acridine, 3-nitro-)
• 14252-03-0(9-Acridinamine,3-nitro-)
• 23045-35-4(9-Acridinamine,2-nitro-)